The predictive value of psychopathological subclassifications for the neuroleptic treatment outcome in schizophrenia.
In the group of 58 schizophrenic patients who fulfilled the DSM-III-R criteria for schizophrenia, various subgroups have been identified according to the DSM-III-R subdivision of schizophrenic types, the DCR classification of systematic, nonsystematic schizophrenia and cycloid psychosis, as well as positive/negative symptoms of schizophrenia. All patients underwent therapy with one neuroleptic from four different neuroleptic groups. Some significant differences between the subgroups in respect to sociodemographic data were found. The DCR subdivision of patients revealed the majority of meaningful data regarding the predictive validity of psychopathology for the outcome of the neuroleptic treatment.
Division of Psychopathology, Institute of Neurology and Psychiatry, Medical Academy Szczecin, Poland.
M
M
Jarema
J
J
Kacperczyk
S
S
Kruszynski
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data*; D011594:Psychometrics; D012559:Schizophrenia / Q000145:classification / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents